Feras Q. Alali

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Novel pyridine-based chalcone analogs and triple negative breast cancer: potential therapy & molecular pathways.

Novel pyridine-based chalcone analogs and triple negative breast cancer: potential therapy & molecular pathways.

Journal: Scientific reports

Published: January 27, 2026

Design, synthesis and biological evaluation of novel chalcone analogs against castration-resistant prostate cancer.

Design, synthesis and biological evaluation of novel chalcone analogs against castration-resistant prostate cancer.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 13, 2025

The Role of Natural Chalcones and Their Derivatives in Targeting Prostate Cancer: Recent Updates.

The Role of Natural Chalcones and Their Derivatives in Targeting Prostate Cancer: Recent Updates.

Journal: International journal of molecular sciences

Published: November 12, 2025

Lung Adenocarcinoma With Bone Metastases: Clinicogenomic Profiling and Insights Into Prognostic Factors.

Lung Adenocarcinoma With Bone Metastases: Clinicogenomic Profiling and Insights Into Prognostic Factors.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: March 25, 2025

Methanolic Leaves Extract of Ziziphus spina-christi Inhibits Cell Proliferation and Migration of HER2-Positive Breast Cancer via p38 MAPK Signaling Pathway.

Methanolic Leaves Extract of Ziziphus spina-christi Inhibits Cell Proliferation and Migration of HER2-Positive Breast Cancer via p38 MAPK Signaling Pathway.

Journal: International journal of molecular sciences

Published: November 27, 2024

Transcriptome analysis revealed a novel nine-gene prognostic risk score of clear cell renal cell carcinoma.

Transcriptome analysis revealed a novel nine-gene prognostic risk score of clear cell renal cell carcinoma.

Journal: Medicine

Published: September 27, 2024

The apoptotic and anti-proliferative effects of Neosetophomone B in T-cell acute lymphoblastic leukaemia via PI3K/AKT/mTOR pathway inhibition.

The apoptotic and anti-proliferative effects of Neosetophomone B in T-cell acute lymphoblastic leukaemia via PI3K/AKT/mTOR pathway inhibition.

Journal: Cell proliferation

Published: August 11, 2024

Network pharmacology, molecular simulation, and binding free energy calculation-based investigation of Neosetophomone B revealed key targets for the treatment of cancer.

Network pharmacology, molecular simulation, and binding free energy calculation-based investigation of Neosetophomone B revealed key targets for the treatment of cancer.

Journal: Frontiers in pharmacology

Published: December 09, 2023

Exploring the in vivo anti-cancer potential of Neosetophomone B in leukemic cells using a zebrafish xenograft model.

Exploring the in vivo anti-cancer potential of Neosetophomone B in leukemic cells using a zebrafish xenograft model.

Journal: Experimental cell research

Published: December 09, 2023

Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis.

Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis.

Journal: Medicine

Published: September 08, 2023

Efficacy and tolerability of sulforaphane in the therapeutic management of cancers: a systematic review of randomized controlled trials.

Efficacy and tolerability of sulforaphane in the therapeutic management of cancers: a systematic review of randomized controlled trials.

Journal: Frontiers in oncology

Published: July 02, 2023

In vitro evaluation of Neosetophomone B inducing apoptosis in cutaneous T cell lymphoma by targeting the FOXM1 signaling pathway.

In vitro evaluation of Neosetophomone B inducing apoptosis in cutaneous T cell lymphoma by targeting the FOXM1 signaling pathway.

Journal: Journal of dermatological science

Published: May 16, 2023

Showing 1-12 of 40

Last Updated: 09/26/2026